Ikibazo gihuza ibibazo · Hagati Urwego
Imiti ya Recursion Imiti ya AI
Gerageza uburyo Recursion ihindura amashusho ya selile muntoki za fenomique kandi ugereranya selile zangiritse hamwe nibisobanuro byiza kugirango ushire imbere abakandida.
Ikibazo 1 Bya 8
Ni ubuhe bwoko bwibanze bwamakuru Recursion ikoresha mugutoza imiterere ya AI?
Reba buri kibazo8 ibibazo
Ibisubizo nibisobanuro bigaragara mugihe ufata ikibazo.
- Ni ubuhe bwoko bwibanze bwamakuru Recursion ikoresha mugutoza imiterere ya AI?
- Microscope amashusho yingirabuzimafatizo zabantu
- Ibyanditswe byubuzima bwa elegitoroniki
- Intungamubiri za poroteyine
- Urutonde rukurikirana rusoma gusa
- Ubuhanga bwo gushushanya Akagari bukora iki?
- Amabara ibikoresho bya laboratoire yo gukurikirana
- Ihinduranya ingirangingo hamwe na fluorescent irangi kumashusho menshi
- Shushanya ibibyimba mugihe cyo kubagwa
- Ongeraho ibimenyetso byamazi ya AI kumashusho
- Kuki Recursion ikoresha ibyiciro biremereye-bikosora amakuru yayo?
- Kugabanya ingano ya dosiye
- Kumenyekanisha amakuru yabarwayi
- Gukuraho ibihangano bya tekiniki bityo ibimenyetso byibinyabuzima byiganje
- Kwihutisha kugenda kwa robo
- Niyihe sosiyete yashoye miliyoni 50 muri Recursion muri 2023?
- Pfizer
- Tesla
- Amazon
- NVIDIA
- Muri 2024, Recursion yahujwe niyihe sosiyete ivumbura ibiyobyabwenge AI?
- Exscientia
- Insitro
- Isomorphic Labs
- DeepMind
- Ni ikihe kintu cyingenzi cyukuri-cyisi cya platform ya Recursion?
- Umubare w'amashusho yakozwe
- Niba abakandida bakomoka kuri AI batsinze ibizamini bya kliniki
- Umuvuduko wa robo
- Guhuza imbuga nkoranyambaga
- What does Recursion's phenomics pipeline produce from images of perturbed cells?
- A complete clinical diagnosis for each patient
- A three-dimensional protein structure for every compound
- Numerical fingerprints that summarize cellular morphology
- A direct measurement of a drug's approval probability
- How can Recursion use a phenomic fingerprint to nominate a possible drug hit?
- Select the compound with the brightest microscope image in every assay
- Choose the compound that changes no measured cell features
- Assume a similar fingerprint proves clinical effectiveness in people
- Look for a compound that shifts disease-altered cells toward a healthy reference state